Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

CombiChem achieves milestone in Roche Bioscience collaboration

May 18, 1998

Phytera and Galileo enter into collaborative agreement

May 18, 1998

Andaris granted U.S. patent for microcapsule technology

May 15, 1998

CombiChem achieves milestone in collaboration with Teijin

May 14, 1998

VP22 provides intercellular delivery of functional p53 protein

May 14, 1998

Evotec awarded German grant for drug discovery

May 13, 1998

Rights to bgh gene tool available from RCT

May 12, 1998

Invitrogen will market reagents based on Phogen's VP22 technology

May 11, 1998

Nexell initiates phase I/II clinical trial of genetically corrected CD34 cells

May 7, 1998

Fuisz and Pfizer enter drug delivery collaboration

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...